CYBIN INC. current report, Q1 FY2023

Business Context and Reporting Period

Cybin Inc. filed this Form 6-K as a foreign private issuer for the month of February 2023. The filing was signed on February 28, 2023, by Doug Drysdale, Chief Executive Officer. The filing identifies an attached News Release dated February 28, 2023, as Exhibit 99.1, but the exhibit content is not included in the provided filing text.

Financial and Operating Metrics

The provided filing text does not include revenue, profit or loss, cash flow, margins, debt, liquidity, operating results, or other financial metrics.

Material Changes Versus Prior Period

The filing text does not provide information sufficient to assess material changes from a prior comparable period.

Guidance, Outlook, Risks, and Unusual Items

No guidance, outlook, management commentary, risks, contingencies, or unusual items are described in the provided filing text. Any such information may be contained in Exhibit 99.1, which is referenced but not provided.

Investor Verification Items

  • Obtain and review Exhibit 99.1, the February 28, 2023 news release.
  • Verify whether the news release contains financial, clinical, financing, corporate, or other material disclosures.
  • Confirm the company’s applicable annual reporting form and related financial statements in the company’s other SEC filings.